» Articles » PMID: 37559114

Possible High Risk of Transmission of the Nipah Virus in South and South East Asia: a Review

Abstract

Nipah virus (NiV) is a zoonotic, single-stranded RNA virus from the family Paramyxoviridae, genus Henipavirus. NiV is a biosafety-level-4 pathogen that is mostly spread by Pteropus species, which serve as its natural reservoir host. NiV is one of the major public health challenges in South and South East Asia. However, few molecular studies have been conducted to characterise NiV in a specific region. The main objective of this review is to understand the epidemiology, pathogenesis, molecular surveillance, transmission dynamics, genetic diversity, reservoir host, clinical characteristics, and phylogenetics of NiV. South and South East Asian nations have experienced NiV outbreaks. Phylogenetic analysis confirmed that two primary clades of NiV are in circulation. In humans, NiV causes severe respiratory illness and/or deadly encephalitis. NiV is mainly diagnosed by ELISA along with PCR. Therefore, we recommend that the governments of the region support the One Health approach to reducing the risk of zoonotic disease transmission in their respective countries.

Citing Articles

Risk of Nipah Virus Seroprevalence in Healthcare Workers: A Systematic Review with Meta-Analysis.

Ricco M, Cascio A, Costantino C, Corrado S, Zanella I, Giuri P Viruses. 2025; 17(1).

PMID: 39861870 PMC: 11768436. DOI: 10.3390/v17010081.


Risk Evaluation and Mitigation Strategies for Potential Outbreaks of Nipah Virus Infection: Evidenced by the Recent Incidences in Southeast Asian Countries.

Rahman M, Shanjana Y, Cronmiller S, Zong D, Davis R, Ernest J Health Sci Rep. 2024; 7(12):e70239.

PMID: 39633840 PMC: 11615790. DOI: 10.1002/hsr2.70239.


Zoonotic Paramyxoviruses: Evolution, Ecology, and Public Health Strategies in a Changing World.

Branda F, Pavia G, Ciccozzi A, Quirino A, Marascio N, Matera G Viruses. 2024; 16(11).

PMID: 39599803 PMC: 11599060. DOI: 10.3390/v16111688.


Immunogenicity and Neutralization of Recombinant Vaccine Candidates Expressing F and G Glycoproteins against Nipah Virus.

Moon S, Flores R, Yim M, Lim H, Kim S, Lee S Vaccines (Basel). 2024; 12(9).

PMID: 39340029 PMC: 11436239. DOI: 10.3390/vaccines12090999.


A tale of endurance: bats, viruses and immune dynamics.

Apoorva , Singh S Future Microbiol. 2024; 19(9):841-856.

PMID: 38648093 PMC: 11382704. DOI: 10.2217/fmb-2023-0233.


References
1.
Yadav P, Sahay R, Balakrishnan A, Mohandas S, Radhakrishnan C, Gokhale M . Nipah Virus Outbreak in Kerala State, India Amidst of COVID-19 Pandemic. Front Public Health. 2022; 10:818545. PMC: 8891450. DOI: 10.3389/fpubh.2022.818545. View

2.
Eaton B, Broder C, Middleton D, Wang L . Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol. 2005; 4(1):23-35. PMC: 7097447. DOI: 10.1038/nrmicro1323. View

3.
Ciancanelli M, Basler C . Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J Virol. 2006; 80(24):12070-8. PMC: 1676283. DOI: 10.1128/JVI.01743-06. View

4.
Rockx B, Winegar R, Freiberg A . Recent progress in henipavirus research: molecular biology, genetic diversity, animal models. Antiviral Res. 2012; 95(2):135-49. DOI: 10.1016/j.antiviral.2012.05.008. View

5.
Rahman M, Islam M, Hossain M, Rahman M, Siddika A, Hossain M . Genetic diversity of Nipah virus in Bangladesh. Int J Infect Dis. 2020; 102:144-151. DOI: 10.1016/j.ijid.2020.10.041. View